Neurofibromatosis type 2

作者: Gareth R Evans , Simon KW Lloyd , Richard T Ramsden

DOI: 10.1136/JMG.37.12.897

关键词:

摘要: Neurofibromatosis type 2 is an often devastating autosomal dominant disorder which, until relatively recently, was confused with its more common namesake neurofibromatosis 1. Subjects who inherit a mutated allele of the NF2 gene inevitably develop schwannomas, affecting particularly superior vestibular branch 8th cranial nerve, usually bilaterally. Meningiomas and other benign central nervous system tumours such as ependymomas are features. Much morbidity from these results their treatment. It now possible to identify mutation in most families, although about 20% apparently sporadic cases actually mosaic for mutation. As classical tumour suppressor, inactivation product, merlin/schwannomin, leads development both associated tumours. Merlin/schwannomin associates proteins at cell cytoskeleton near plasma membrane it inhibits proliferation, adhesion, migration.

参考文章(93)
J. Gusella, D. Pinney, C. Gonzalez-Agosti, W. Hobbs, V. Ramesh, R. Beauchamp, L. Xu, The merlin tumor suppressor localizes preferentially in membrane ruffles. Oncogene. ,vol. 13, pp. 1239- 1247 ,(1996)
William J. Schull, James V. Neel, Frank W. Crowe, A clinical, pathological, and genetic study of multiple neurofibromatosis C.C. Thomas. ,(1956)
M MacCollin, V Ramesh, Lee B Jacoby, David N Louis, Mari-Paz Rubio, Karen Pulaski, James A Trofatter, M Priscilla Short, C Bove, Roswell Eldridge, Dilys M Parry, James F Gusella, Mutational analysis of patients with neurofibromatosis 2 American Journal of Human Genetics. ,vol. 55, pp. 314- 320 ,(1994)
S. Rangaratnam, A. A. Andermann, M. MacCollin, D. Parry, G. A. Rouleau, B. D. Hall, F. Y. Han, P. Short, P. Propping, V. Michels, K. Kitamura, V. M. Riccardi, J. M. Bradburn, J. O. Claudio, N. Chretien, R. Weksberg, C. M. Phelan, M. H. Ruttledge, Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. American Journal of Human Genetics. ,vol. 59, pp. 331- 342 ,(1996)
Marina Frontali, James F. Gusella, Steven A. Narod, Robert L. Martuza, Martin Ruttledge, Dilys M. Parry, Guy A. Rouleau, Roswell Eldridge, Jillian Parboosingh, Gilbert M. Lenoir, Jonathan Haines, Georges Fischer, Neurofibromatosis type 2 appears to be a genetically homogeneous disease American Journal of Human Genetics. ,vol. 51, pp. 486- 496 ,(1992)
J F Gusella, M M MacCollin, D M Parry, M I Kaiser-Kupfer, K Pulaski, M Bolesta, H S Nicholson, R Eldridge, Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. American Journal of Human Genetics. ,vol. 59, pp. 529- 539 ,(1996)
K A Frazer, R K Jackler, D R Cox, L H Pitts, M J Lanser, R K Wolff, Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors. American Journal of Human Genetics. ,vol. 51, pp. 478- 485 ,(1992)
Jeffrey Allen, Roswell Eldridge, Thelma Koerber, Acoustic neuroma in the last months of pregnancy American Journal of Obstetrics and Gynecology. ,vol. 119, pp. 516- 520 ,(1974) , 10.1016/0002-9378(74)90212-9